Andersen D K, Ruiz C L, Burant C F
Department of Surgery, University of Chicago, Illinois.
Ann Surg. 1994 Jun;219(6):679-86; discussion 686-7. doi: 10.1097/00000658-199406000-00011.
The effect of chronic pancreatitis and insulin on the expression of the hepatic facilitative glucose transporter protein (GLUT-2) was determined in rats.
Chronic pancreatitis is associated with diabetes mellitus or impaired glucose tolerance. Suppression of hepatic glucose production (HGP) by insulin is impaired, although the mechanism is unknown.
Normal rats, rats with chronic pancreatitis induced 12 to 16 weeks earlier by oleic acid injection into the pancreatic ducts, and sham-operated rats were studied. Isolated, single-pass liver perfusion was performed, during which glucagon (1.2 pM) was infused, with or without insulin (0.6 or 1.2 nM). The suppression of HGP production by insulin was compared with changes in GLUT-2 in the membrane fraction of liver biopsies obtained before and after hormone perfusion.
Glycogen-rich (fed) livers of normal rats (n = 16) demonstrated a dose-dependent suppression of hepatic glucose production by insulin (50 +/- 5% HGP induced by glucagon alone during 1.2-nM insulin perfusion) and a dose-dependent decrease in GLUT-2 (30 +/- 13% of basal level during 1.2-nM insulin perfusion). Sham-operated rats (n = 6) also showed reductions in HGP (51 +/- 4%) and GLUT-2 (14 +/- 10%) during 1.2-nM insulin perfusion. In contrast, rats with chronic pancreatitis (n = 6) showed no suppression of HGP during 1.2-nM insulin perfusion, and an increase in GLUT-2 (+20 +/- 6%) after insulin perfusion (p < 0.02 vs. sham).
Insulin suppresses glucagon-stimulated HGP in normal and sham-operated rats, and this reduction in HGP is associated with a decrease in the membrane-bound quantity of GLUT-2. In chronic pancreatitis, insulin suppression of HGP is absent, and this is accompanied by an increase in GLUT-2 in the hepatocyte membrane. The authors conclude that the insulin-mediated change in the level of hepatocyte GLUT-2 is impaired in chronic pancreatitis, and may contribute to the altered glucose metabolism observed commonly in this disease.
在大鼠中确定慢性胰腺炎和胰岛素对肝脏易化葡萄糖转运蛋白(GLUT-2)表达的影响。
慢性胰腺炎与糖尿病或糖耐量受损有关。胰岛素对肝糖生成(HGP)的抑制作用受损,但其机制尚不清楚。
研究正常大鼠、12至16周前通过向胰管注射油酸诱导慢性胰腺炎的大鼠以及假手术大鼠。进行离体单通道肝脏灌注,期间输注胰高血糖素(1.2 pM),同时或不添加胰岛素(0.6或1.2 nM)。将胰岛素对HGP产生的抑制作用与激素灌注前后获得的肝脏活检膜部分中GLUT-2的变化进行比较。
正常大鼠(n = 16)富含糖原(进食后)的肝脏显示胰岛素对肝糖生成有剂量依赖性抑制(在1.2 nM胰岛素灌注期间,仅胰高血糖素诱导的HGP为50 +/- 5%),并且GLUT-2有剂量依赖性降低(在1.2 nM胰岛素灌注期间为基础水平的30 +/- 13%)。假手术大鼠(n = 6)在1.2 nM胰岛素灌注期间HGP(51 +/- 4%)和GLUT-2(14 +/- 10%)也有降低。相比之下,慢性胰腺炎大鼠(n = 6)在1.2 nM胰岛素灌注期间未显示HGP受到抑制,且胰岛素灌注后GLUT-2增加(+20 +/- 6%)(与假手术组相比,p < 0.02)。
胰岛素抑制正常大鼠和假手术大鼠中胰高血糖素刺激的HGP,且HGP的这种降低与膜结合的GLUT-2量的减少有关。在慢性胰腺炎中,胰岛素对HGP的抑制作用缺失,且这伴随着肝细胞膜中GLUT-2的增加。作者得出结论,慢性胰腺炎中胰岛素介导的肝细胞GLUT-2水平变化受损,这可能导致该疾病中常见的糖代谢改变。